Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014312
Filing Date
2023-08-09
Accepted
2023-08-09 17:01:01
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pxmd-20230630x10q.htm   iXBRL 10-Q 1228930
2 EX-10.1 pxmd-20230630xex10d1.htm EX-10.1 133197
3 EX-31.1 pxmd-20230630xex31d1.htm EX-31.1 13354
4 EX-31.2 pxmd-20230630xex31d2.htm EX-31.2 15399
5 EX-32.1 pxmd-20230630xex32d1.htm EX-32.1 6790
6 EX-32.2 pxmd-20230630xex32d2.htm EX-32.2 6820
7 GRAPHIC pxmd-20230630xex10d1001.jpg GRAPHIC 999
8 GRAPHIC pxmd-20230630xex10d1002.jpg GRAPHIC 939
  Complete submission text file 0001558370-23-014312.txt   6124792

Data Files

Seq Description Document Type Size
9 EX-101.SCH pxmd-20230630.xsd EX-101.SCH 47287
10 EX-101.CAL pxmd-20230630_cal.xml EX-101.CAL 36010
11 EX-101.DEF pxmd-20230630_def.xml EX-101.DEF 184093
12 EX-101.LAB pxmd-20230630_lab.xml EX-101.LAB 410644
13 EX-101.PRE pxmd-20230630_pre.xml EX-101.PRE 306154
58 EXTRACTED XBRL INSTANCE DOCUMENT pxmd-20230630x10q_htm.xml XML 955555
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Filer) CIK: 0001811623 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41475 | Film No.: 231156089
SIC: 2834 Pharmaceutical Preparations